Monkeypox - review
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.083Keywords
monkeypox, zoonosis, tecovirimatAbstract
Introduction and purpose:
This review aims to analyze the current information about monkeypox and the virus which causes the disease.
Material and method:
This review was based on articles collected in PubMed and published in the years 2012-2022
The research was done by looking through keywords as follows: „monkeypox”; „zoonosis”;„tecovirimat”
Results:
The selected studies have demonstrated that the monkeypox virus is a high-danger pathogen that causes a disease important to public health. More research on this topic has to be done to prevent and better comprehend the potential threat.
Conclusions:
According to the cited research, public health systems should be aware of practical methods to reduce the risk of monkeypox spreading. It is crucial to monitor the spreading of the monkeypox disease and create effective preparation. Moreover, governments should develop strategies to prevent their population.
References
World Health Organization (2022), Monkeypox, https://www.who.int/news-room/fact-sheets/detail/monkeypox (access: 09.08.2022)
Sklenovská N, Van Ranst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Front Public Health. 2018 Sep 4;6:241. doi: 10.3389/fpubh.2018.00241.
Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A. Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043. doi: 10.1016/j.idc.2019.03.001.
Hraib M, Jouni S, Albitar MM, Alaidi S, Alshehabi Z. The outbreak of monkeypox 2022: An overview. Ann Med Surg (Lond). 2022 Jun 24;79:104069. doi: 10.1016/j.amsu.2022.104069.
Mbala PK, Huggins JW, Riu-Rovira T, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis 2017;216:824-828.
John P. Thornhill, M.D., Ph.D., Sapha Barkati, M.D., Sharon Walmsley, M.D., et al., Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022. The New England Journal of Medicine. 2022 Jul 21; DOI: 10.1056/NEJMoa2207323
Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141. doi: 10.1371/journal.pntd.0010141
World Health Organization (2022), 2022 Monkeypox Outbreak: Global Trends, https://worldhealthorg.shinyapps.io/mpx_global/ (access: 11.08.2022)
Zhang Y, Zhang JY, Wang FS. Monkeypox outbreak: A novel threat after COVID-19? Mil Med Res. 2022 Jun 13;9(1):29. doi: 10.1186/s40779-022-00395-y.
Cabanillas B, Valdelvira R, Akdis CA. Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease. Allergy. 2022 Aug;77(8):2284-2286. doi: 10.1111/all.15393
Reynolds MG, Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol. 2012 Feb;20(2):80-7. doi: 10.1016/j.tim.2011.12.001.
Kozlov M. Monkeypox outbreaks: 4 key questions researchers have. Nature. 2022 Jun;606(7913):238-239. doi: 10.1038/d41586-022-01493-6
Durski KN, McCollum AM, Nakazawa Y, Petersen BW, Reynolds MG, Briand S, Djingarey MH, Olson V, Damon IK, Khalakdina A. Emergence of Monkeypox - West and Central Africa, 1970-2017. MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):306-310. doi: 10.15585/mmwr.mm6710a5.
Walter K, Malani PN. What Is Monkeypox? JAMA. 2022 Jul 12;328(2):222. doi: 10.1001/jama.2022.10259.
Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and Treatment of Monkeypox. Drugs. 2022 Jun;82(9):957-963. doi: 10.1007/s40265-022-01742-y.
Sherwat A, Brooks JT, Birnkrant D, Kim P. Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations. N Engl J Med. 2022 Aug 3. doi: 10.1056/NEJMp2210125.
Russo AT, Grosenbach DW, Chinsangaram J, Honeychurch KM, Long PG, Lovejoy C, Maiti B, Meara I, Hruby DE. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther. 2021 Mar;19(3):331-344. doi: 10.1080/14787210.2020.1819791.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Aleksandra Amalia Kuchnicka, Katarzyna Kosz, Julia Kuchnicka, Klaudia Remjasz, Natalia Zarankiewicz, Martyna Zielińska, Klaudia Sapuła, Jakub Aleksandrowicz, Wojciech Siedlecki
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 137
Number of citations: 0
